Health Catalyst, Inc.
Data quality: 100%
HCAT
Nasdaq
Technology
IT Services
$1.01
▼
$0.03
(-2.43%)
Mkt Cap: 73.95 M
Price
$1.01
Mkt Cap
73.95 M
Day Range
$0.97 — $1.03
52-Week Range
$0.97 — $5.06
Volume
511,026
Open $1.03
50D / 200D Avg
$1.70
40.99% below
50D / 200D Avg
$2.71
62.92% below
Quick Summary
Key Takeaways
Revenue grew 6.49% annually over 5 years — modest growth
Debt/Equity of 0.46 — conservative balance sheet
Negative free cash flow of -237,000.0
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.01%
Capital efficient — spends only 0.31% of revenue on capex
Growth
Revenue Growth (5Y)
6.49%
Below sector avg (9.35%)
Revenue (1Y)1.48%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-52.39%
Below sector avg (8.56%)
ROIC-25.00%
Net Margin-57.20%
Op. Margin-51.70%
Safety
Debt / Equity
0.46
Above sector avg (0.44)
Current Ratio1.88
Interest CoverageN/A
Valuation
PE (TTM)
-0.42
Below sector avg (18.70)
P/B Ratio0.22
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Technology sector median (611 peers)
Peer Comparison
vs Technology sector median (611 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.4 | 18.7 |
| P/B | 0.2 | 4.5 |
| ROE % | -52.4 | 8.6 |
| Net Margin % | -57.2 | 5.6 |
| Rev Growth 5Y % | 6.5 | 9.4 |
| D/E | 0.5 | 0.4 |
ETFs Holding This Stock
0.02% weight
0.02% weight
0.01% weight
0.00% weight
0.00% weight
0.00% weight
0.00% weight
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 1.48% | Revenue Growth (3Y) | 2.54% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 6.49% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 311.14 M | Net Income (TTM) | -177.97 M |
| ROE | -52.39% | ROA | -29.58% |
| Gross Margin | N/A | Operating Margin | -51.70% |
| Net Margin | -57.20% | Free Cash Flow (TTM) | -237,000.0 |
| ROIC | -25.00% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.46 | Current Ratio | 1.88 |
| Interest Coverage | N/A | Asset Turnover | 0.52 |
| Working Capital | 77.46 M | Tangible Book Value | -43.22 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.42 | Forward P/E | N/A |
| P/B Ratio | 0.22 | P/S Ratio | 0.24 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0.32% | ||
| Market Cap | 73.95 M | Enterprise Value | 186.79 M |
| Per Share | |||
| EPS (Diluted TTM) | -2.55 | Revenue / Share | 4.23 |
| FCF / Share | 0.00 | OCF / Share | 0.01 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 0.31% | FCF Conversion | 0.13% |
| SBC-Adj. FCF | -32.65 M | Growth Momentum | -5.01 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 311.14 M | 306.58 M | 295.94 M | 276.24 M | 241.93 M |
| Net Income | -177.97 M | -69.50 M | -118.15 M | -137.40 M | -153.21 M |
| EPS (Diluted) | -2.55 | -1.15 | -2.09 | -2.63 | -3.23 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -160.85 M | -69.81 M | -126.90 M | -140.01 M | -143.65 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 49.77 M | 57.95 M | 72.63 M | 75.68 M | 62.73 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 50.50 M | 41.43 M | 42.22 M | 48.30 M | 37.53 M |
| Interest Expense | — | — | — | — | — |
| Income Tax | 716,000.0 | 333,000.0 | 356,000.0 | -4.28 M | -6.90 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 502.64 M | 858.93 M | 701.81 M | 752.29 M | 832.10 M |
| Total Liabilities | 256.86 M | 493.72 M | 334.90 M | 327.28 M | 310.00 M |
| Shareholders' Equity | 245.78 M | 365.21 M | 366.92 M | 425.01 M | 522.10 M |
| Total Debt | 153.25 M | 382.36 M | 228.03 M | 226.52 M | 180.94 M |
| Cash & Equivalents | 50.81 M | 249.65 M | 106.28 M | 116.31 M | 193.23 M |
| Current Assets | 169.31 M | 465.65 M | 393.40 M | 427.80 M | 508.39 M |
| Current Liabilities | 89.57 M | 325.85 M | 89.03 M | 82.51 M | 93.05 M |
{"event":"ticker_viewed","properties":{"ticker":"HCAT","listing_kind":"stock","pathname":"/stocks/hcat","exchange":"Nasdaq","country":"US"}}






